Kempson, James published the artcileSynthesis Optimization, Scale-Up, and Catalyst Screening Efforts toward the MGAT2 Clinical Candidate, BMS-963272, Safety of (S)-2-Methylpropane-2-sulfinamide, the main research area is tetrazolyltolyl trifluorobutoxyphenyl trifluoromethyl dihydropyridinone enantioselective preparation.
This paper describes the efficient scale-up synthesis of 1 (BMS-963272) which relies upon a highly selective Mannich-type alkylation strategy to stereospecifically install a quaternary carbon center. An intramol. cyclization reaction was also used to form the aryl dihydropyridone (ADHP) core. The optimized route was demonstrated to provide more than 100 g of active pharmaceutical ingredient for preclin. toxicol. evaluation. A catalyst screening effort was also discussed as part of a complimentary convergent approach which will facilitate a more expedient assessment of back-up mols. bearing aryl diversity at the C4-position of the ADHP core.
Organic Process Research & Development published new progress about Cyclization. 343338-28-3 belongs to class amides-buliding-blocks, name is (S)-2-Methylpropane-2-sulfinamide, and the molecular formula is C4H11NOS, Safety of (S)-2-Methylpropane-2-sulfinamide.
Referemce:
Amide – Wikipedia,
Amide – an overview | ScienceDirect Topics